Translational research funding boost
24 November 2017
A prestigious award from the National Health and Medical Research Council (NHMRC) has been presented to Associate Professor Rachael Morton, an Investigator at Melanoma Institute Australia and Research Theme Leader for Society, Policy and Economics.
The NHMRC Translating Research Into Practice (TRIP) Fellowship aims to support future leaders to undertake projects focused on translating evidence into practice that will have a deep impact on health care.
The funding will help researchers at Melanoma Institute Australia continue their ground-breaking research in melanoma that will change the way melanoma treatment is assessed in the future.
A/Prof Morton will use the funding to incorporate Patient Reported Outcome Measures (PROMs) into clinical quality registries.
“PROMs are an important method to better understand outcomes that matter to patients and include any metric assessing health, illness or health care benefits from the patient’s perspective, such as a questionnaire,” explains A/Prof Morton. “In the clinic, PROMs have the potential to highlight relevant symptoms and changes in symptoms, promote patient engagement in their treatment and improve patient outcomes.”
“Instruments measuring the patient’s perspective have been available for decades; however their incorporation into routine clinical practice has until recently been slow. We hope to facilitate this process.”
The work from this Fellowship will help integrate PROMs into the new Australian Clinical Outcomes Register for Melanoma, also known as the Big Data for Melanoma project, which has been made possible by collective fundraising efforts from the national Melanoma March campaign.
Australian researchers have played a critical role in the discovery of a potential new test to predict which early stage melanoma patients are at high risk of their disease recurring and progressing.
We are extremely grateful for our community fundraisers, who, even in this difficult time, have given up their time and effort to fundraise so we can continue to work towards our goal of zero deaths from melanoma.
Melanoma patients are set to benefit from subsidised access to immunotherapy treatment for high risk early-stage and advanced-stage melanoma patients.
An informative article on how immunotherapy is revolutionising cancer treatment, written by Jill Margo and featured in the Australian Financial Review.
Melanoma patients and their families in the Riverina will benefit from strengthened and sustained melanoma services with the merger of the Amie St Clair Melanoma Trust and Melanoma Institute Australia.
Belmont High School at Lake Macquarie has been announced winner of the 2019 SunSafe Student Ambassador Program video competition.
It’s time again to say thank you to our amazing community fundraisers!
Videos of the sessions at the recent Patient Information Evening co-hosted by Melanoma Institute Australia (MIA) and Melanoma Patients Australia (MPA) are now available for viewing.
MIA is well-represented in the poster sessions at the Society for Melanoma Research 2019 Congress in the USA, with four poster presentations being given by members of our translational research lab.
Professor Georgina Long has today opened the Society for Melanoma Research 2019 Congress in Salt Lake City, Utah.
MIA’s Co-Medical Directors, Professor Georgina Long and Professor Richard Scolyer, have both been named Highly Cited Researchers, according to the Clarivate Analytics Highly Cited Researchers 2019 list.
Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA) have announced a new multi-year agreement to provide enhanced support services for melanoma patients nationally.
It is time again to say thank you to our incredible community fundraisers who are helping us get closer to our goal of zero deaths from melanoma.
MIA has presented promising data regarding progression-free survival rates for advanced melanoma patients at the ESMO 2019 Congress in Barcelona.
Another month has flown by and yet again we have a host of amazing community fundraisers who generously gave up their time to help us reach our goal of zero deaths from melanoma.
Comments in favour of giving patients with BRAF-positive melanoma access to first-line immunotherapy need to be submitted online prior to October 9, 2019.
Jay's Longest Melanoma March documentary is screening this Sunday 22 September at 1pm (AEST) on Channel 10, capturing behind the scenes of the 2000km walk, Adelaide to Sydney in 50 days. Uniting to end melanoma.
It’s been a month since we highlighted some of our incredibly generous community fundraisers. We thought we’d have a look back at August and put the spotlight on more of the wonderful people who give up their time to fundraise for MIA, so we can continue to edge closer to our goal of zero deaths from melanoma.